Class IIOngoing
Dextroamphetamine Saccharate recall
FDA recall D-0660-2026 · initiated Jun 26, 2026
By the pharmaranks editorial teamReviewed against the FDA (openFDA) sourcesUpdated Jul 8, 2026How we research
Lannett Company Inc. recalled Dextroamphetamine Saccharate in Jun 2026 — an FDA Class II recall (D-0660-2026) because Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
Details
- Product
- Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.
- Recalling company
- Lannett
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- US Nationwide.
- Initiated
- Jun 26, 2026
- FDA report date
- Jul 8, 2026
Frequently asked
- Was Dextroamphetamine Saccharate recalled?
- Lannett Company Inc. recalled Dextroamphetamine Saccharate in Jun 2026 — an FDA Class II recall (D-0660-2026) because Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Dextroamphetamine Saccharate recalled?
- Per the FDA enforcement record, the reason for recall D-0660-2026 was: Labeling: Label Mix-up: Capsules contain only immediate-release (IR) pellets while labeled as ER capsules.
- Is a recalled Dextroamphetamine Saccharate dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Dextroamphetamine Saccharate are affected?
- Distribution: US Nationwide.. The affected lot numbers and expiration dates are listed in the official FDA enforcement record for recall D-0660-2026, initiated Jun 2026.